(Q24620135)

English

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 June 2017

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study (English)

1 reference

Europe PubMed Central

23 June 2017

post-traumatic stress disorder

0 references

author name string

Michael C Mithoefer

1

1 reference

Europe PubMed Central

23 June 2017

Mark T Wagner

2

1 reference

Europe PubMed Central

23 June 2017

Ann T Mithoefer

3

1 reference

Europe PubMed Central

23 June 2017

Lisa Jerome

4

1 reference

Europe PubMed Central

23 June 2017

Scott F Martin

5

1 reference

Europe PubMed Central

23 June 2017

Berra Yazar-Klosinski

6

1 reference

Europe PubMed Central

23 June 2017

Yvonne Michel

7

1 reference

Europe PubMed Central

23 June 2017

Timothy D Brewerton

8

1 reference

Europe PubMed Central

23 June 2017

Rick Doblin

9

1 reference

Europe PubMed Central

23 June 2017

language of work or name

0 references

publication date

20 November 2012

1 reference

Europe PubMed Central

23 June 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

23 June 2017

27

1 reference

Europe PubMed Central

23 June 2017

1

1 reference

Europe PubMed Central

23 June 2017

28-39

1 reference

Europe PubMed Central

23 June 2017

Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

7 April 2017

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

The placebo response: how words and rituals change the patient's brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Effects of MDMA on sociability and neural response to social threat and social reward

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

The harmful health effects of recreational ecstasy: a systematic review of observational evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Treatment of post-traumatic stress disorder with eye movement desensitization and reprocessing: outcome is stable in 35-month follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

The neuropsychology of ecstasy (MDMA) use: a quantitative review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Ecstasy (MDMA) and memory function: a meta-analytic update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

A comprehensive review of the placebo effect: recent advances and current thought

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

MDMA use and neurocognition: a meta-analytic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Longitudinal studies of PTSD: overview of findings and methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Posttraumatic growth in clinical psychology - a critical review and introduction of a two component model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Frontline treatment of combat stress reaction: a 20-year longitudinal evaluation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Neuropsychological function in ecstasy users: a study controlling for polydrug use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Assessing the long-term effects of EMDR: results from an 18-month follow-up study with adult female survivors of CSA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

The epidemiology of posttraumatic stress disorder: what is the extent of the problem?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Clinician-administered PTSD scale: a review of the first ten years of research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Gender differences in the subjective effects of MDMA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Comorbidity of psychiatric disorders and posttraumatic stress disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Substance abuse and post-traumatic stress disorder comorbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

27 September 2017

Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

30 May 2018

Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

30 May 2018

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

30 May 2018

Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

30 May 2018

Subjective reports of the effects of MDMA in a clinical setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

30 May 2018

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

The Posttraumatic Growth Inventory: measuring the positive legacy of trauma.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

What is a "mood stabilizer"? An evidence-based response

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

Long-term course of post-traumatic stress disorder (PTSD) in German soldiers: effects of inpatient eye movement desensitization and reprocessing therapy and specific trauma characteristics in patients with non-combat-related PTSD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

21 January 2018

A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

28 November 2018

VA mental health services utilization in Iraq and Afghanistan veterans in the first year of receiving new mental health diagnoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573678

28 November 2018

Psychological trauma and PTSD symptoms as predictors of substance dependence treatment outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23172889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/23172889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stabilizing group treatment for Complex Posttraumatic Stress Disorder related to childhood abuse based on psycho-education and cognitive behavioral therapy: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23172889

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Abstinence Following Holotropic Breathwork as Adjunctive Treatment of Substance Use Disorders and Related Psychiatric Comorbidity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine treatment in a population of adults with mental retardation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112456611

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1177/0269881112456611

1 reference

Europe PubMed Central

23 June 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Europe PubMed Central

23 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24620135&oldid=1957635224"